Published in Acta Physiol Scand on May 01, 1983
Response of the medullary respiratory network of the cat to hypoxia. J Physiol (1991) 1.23
Adenosinergic modulation of respiratory neurones and hypoxic responses in the anaesthetized cat. J Physiol (1995) 1.11
Increased allopregnanolone levels in the fetal sheep brain following umbilical cord occlusion. J Physiol (2004) 0.85
Rate dependent influence of arterial desaturation on self-selected exercise intensity during cycling. PLoS One (2017) 0.75
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press (1992) 2.49
Benefits obtained by the introduction of a coronary-care unit. A comparative study. Acta Med Scand (1971) 2.29
Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain (1992) 1.89
Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. Eur J Clin Pharmacol (1983) 1.77
Informal and formal care among single-living elderly in Europe. Health Econ (2008) 1.73
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer (2001) 1.71
Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses. Biopharm Drug Dispos (1987) 1.70
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66
Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Br J Clin Pharmacol (1979) 1.66
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer (2000) 1.60
Effects on the child of alcohol abuse during pregnancy. Retrospective and prospective studies. Acta Paediatr Scand Suppl (1979) 1.60
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl (1988) 1.55
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol (1998) 1.55
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ (1994) 1.52
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol (1998) 1.51
Hu protein as an early marker of neuronal phenotypic differentiation by subependymal zone cells of the adult songbird forebrain. J Neurobiol (1995) 1.50
Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population. J Hum Hypertens (2005) 1.45
Postnatal development of bulk flow in the cerebrospinal fluid system of the albino rat: clearance of carboxyl-( 14 C)inulin after intrathecal infusion. Brain Res (1973) 1.44
Psychotropic drug use in pregnancy and perinatal death. Acta Obstet Gynecol Scand (1992) 1.39
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39
Felodipine kinetics in healthy men. Clin Pharmacol Ther (1985) 1.35
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer (2000) 1.34
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology (1988) 1.27
Brain natriuretic peptide predicts mortality in the elderly. Heart (1997) 1.27
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand (1988) 1.27
The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men. J Intern Med (1995) 1.25
Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62. Eur J Clin Pharmacol (1978) 1.24
Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci (Lond) (1981) 1.23
beta-Adrenoceptor blockers, plasma-potassium, and exercise. Lancet (1978) 1.22
Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res (1995) 1.22
Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clin Pharmacol Ther (1990) 1.21
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Adenosine mechanisms in the regulation of breathing in the rat. Eur J Pharmacol (1984) 1.20
Acute diuretic/natriuretic properties of felodipine in man. Drugs (1985) 1.20
Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand (1987) 1.18
Your next of kin or your own career? Caring and working among the 50+ of Europe. J Health Econ (2007) 1.17
Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1980) 1.17
Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol (1991) 1.16
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. Blood Press (1993) 1.15
Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects. Br J Clin Pharmacol (1990) 1.14
Atrial natriuretic peptides predict mortality in the elderly. J Intern Med (1997) 1.14
Short-term effects of felodipine, a new dihydropyridine, in hypertension. Br J Clin Pharmacol (1984) 1.14
Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol (1982) 1.14
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
Subcellular distribution of [3H]amphetamine and [3H]guanethidine and their interaction with adrenergic neurons. J Pharm Pharmacol (1968) 1.12
Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects. Scand J Gastroenterol (1993) 1.11
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol (1998) 1.11
Platelet count after selective beta-receptor blockade. N Engl J Med (1976) 1.10
Treatment of essential hypertension with felodipine in combination with a diuretic. Eur J Clin Pharmacol (1986) 1.10
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain (1994) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
Abnormal ontogeny in young rabbits after chronic administration of haloperidol to the nursing mothers. Brain Res (1972) 1.08
Antihypertensive effects of felodipine compared with placebo. Drugs (1985) 1.07
Perceived symptoms amongst hypertensive patients in routine clinical practice- a population-based study. J Intern Med (1998) 1.03
Ambulatory blood pressure 16-26 years after the first urinary tract infection in childhood. J Hypertens (2000) 1.02
Ketanserin in essential hypertension: effects during rest and exercise. Eur J Clin Pharmacol (1983) 1.02
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis. Virchows Arch (1999) 1.01
Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J Neural Transm (1985) 1.01
Uptake of biogenic amines by two different mechanisms present in adrenergic granules. Br J Pharmacol Chemother (1967) 1.01
Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol (2001) 1.00
The pharmacokinetics of omeprazole in humans--a study of single intravenous and oral doses. Ther Drug Monit (1990) 1.00
Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand (1998) 1.00
Mucosal malignant melanomas. Am J Surg (1980) 1.00
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Drugs during pregnancy: an issue of risk classification and information to prescribers. Drug Saf (1996) 0.99
Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population. Eur Heart J (1993) 0.99
Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. Heart Lung (1997) 0.99
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res (1999) 0.98
Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension. Br J Clin Pharmacol (1984) 0.97
Regulation of breathing in the rat: indications for a role of central adenosine mechanisms. Neurosci Lett (1982) 0.97
Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man. Gut (1988) 0.97
Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol (2001) 0.97
Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. Maturitas (1994) 0.97
Intraarticular morphine after arthroscopic ACL reconstruction: a double-blind placebo-controlled study of 40 patients. Acta Orthop Scand (2000) 0.96
Omeprazole: no evidence for frequent hepatic reactions. Lancet (1984) 0.96
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci (1999) 0.96
Epithelioid cell granulomas in liver biopsies. Scand J Gastroenterol Suppl (1970) 0.95
Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol (1988) 0.95
Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol (2005) 0.95
Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol (1994) 0.95
Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.94
The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality. J Intern Med (2012) 0.94
Pressure-volume relationship and fluid content in fetal rabbit lung after beta-receptor-stimulating drugs. Pediatr Res (1980) 0.94
Renal and hemodynamic effects of isradipine in essential hypertension. Am J Med (1989) 0.94